ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Go Back
Webinar product cover

Management and Cochlear Implantation for TMPRSS3 Genetic Hearing Loss (On Demand Webinar) (PD102894)

Presenter(s): Rebecca Witmer, LCSW; Kaitlyn Mulray, MS, CCC-SLP; Melissa Ferrello, AuD, CCC-A
Course Description

TMPRSS3 is a genetic variant associated with either progressive or congenital bilateral sensorineural hearing loss. Through case studies, this webinar will address multidisciplinary management spanning from diagnosis of hearing loss to cochlear implantation. The presenters will share relevant education for professionals working with children with hearing loss.

Related Courses

This is one of three courses in the ASHA Audiology 2024: Pediatric Audiology webinar series. See all the courses in this series.

Learning Outcomes
You will be able to:

  • Describe the impacts of TMPRSS3 genetic variant on hearing sensitivity
  • Describe the benefits of a multidisciplinary approach to caring for patients with TMPRSS3-related hearing loss
  • Identify cochlear implant candidacy in patients with TMPRSS3-related hearing loss

Contents

  • Gene review
  •  Intro to audiological management and cochlear implantation
  • Adjustment to hearing loss
  • Developmental monitoring and outcomes
  • Q&A/Wrap-up

Presenter Information

Rebecca Witmer, LCSW, is a Licensed Clinical Social Worker at the Children’s Hospital of Philadelphia in the Center for Childhood Communication Integrated Psychosocial Program, where she has provided behavioral health services to deaf and hard of hearing children and their families for more than 10 years. As a member of the Hearing Implant Program, Rebecca provides evaluations and therapy for children and families throughout the cochlear implant candidacy process. In addition to supporting families through their adjustment to hearing loss, Rebecca’s areas of expertise include counseling families regarding learning differences, grief and loss, childhood trauma, foster care, and adoption.

Financial Disclosures:

  • Employed by Children's Hospital of Philadelphia

Nonfinancial Disclosures:

  • None

Kaitlyn Mulray, MS, CCC-SLP (she/her/hers) is a speech-language pathologist in the Center for Childhood Communication at Children’s Hospital of Philadelphia. She received her undergraduate degree from Temple University and her graduate degree from Gallaudet University. Kaitlyn provides comprehensive evaluations and treatment for pediatric patients of all ages with a wide variety of communication, speech, and language delays and disorders. She is a member of the Hearing Implant Program and has specialized clinical interest in working with children with hearing loss. She has also served as clinical fellowship mentor.

Financial Disclosures:

  • Employed by Children's Hospital of Philadelphia

Nonfinancial Disclosures:

  • None

Melissa Ferrello, AuD, CCC-A (she/her/hers) is an audiologist in the Center for Childhood Communication at Children’s Hospital of Philadelphia, with practice in pediatric audiology for nearly 20 years. She graduated with degrees in psychology and computer applications from the University of Notre Dame and received her master’s and doctorate in audiology from Indiana University. Her areas of clinical interest include cochlear implants, other hearing technologies, pediatric tinnitus, and electrophysiologic evaluations.

Financial Disclosures:

  • Employed by Children's Hospital of Philadelphia

Nonfinancial Disclosures:

  • None

Assessment Type

Self-assessment—Think about what you learned and report on the Completion Form how you will use your new knowledge.

To earn continuing education credit, you must complete and submit the learning assessment by the end date below.

Program History and CE Information

Content origination date: June 5, 2024
End date: June 7, 2029

This course is offered for 0.1 ASHA CEUs (Intermediate level, Professional area).

1
Subscribers Ratings
0
CONTINUING EDUCATION
PDH: 1
ASHA CEU*: 0.1
COURSE DETAILS
Item #(s): PD102894
Available Through: June 07, 2029